CORD-19:5e8abc62533a447422d5ead64d4ae4991cc99052 / 11829-12094 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/5e8abc62533a447422d5ead64d4ae4991cc99052","sourcedb":"CORD-19","sourceid":"5e8abc62533a447422d5ead64d4ae4991cc99052","text":"We employed the Discovery Studio program 3.1 designed by Accelrys Inc (San Diego, CA, USA) to dock XKB, midazolam, ketoconazole, and probucol into the active site of human CYP3A4 and rat Cyp3a2 homology model as previously described, 28 but with some modifications.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T81","span":{"begin":0,"end":265},"obj":"Sentence"},{"id":"T63142","span":{"begin":0,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T81","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T63142","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93d3","default":true}]}]}}